|
1. Muller M, den Tonkelaar I, Thijssen JH, et al. Endogenous sex hormones in men aged 40-80 years. Eur J Endocrinol. 2003 Dec;149(6):583-9.
2. Burger HG, Dudley EC, Robertson DM, et al. Hormonal changes in the menopause transition. Recent Prog Horm Res. 2002;57:257-75.
3. Gonzales GF, Gonez C, Villena A. Adrenopause or decline of serum adrenal androgens with age in women living at sea level or at high altitude. J Endocrinol. 2002 Apr;173(1):95-101.
4. Johnson CE, Berman JR. The role of androgens in hormone replacement therapy. Expert Opin Pharmacother. 2005 Sep;6(11):1815-31.
5. Berr C, Lafont S, Debuire B, et al. Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13410-5.
6. Kley HK, Nieschlag E, Wiegelmann W, et al. Sexual hormones in ageing males. Aktuelle Gerontol 1976 Feb;6(2):61-7 (in German).
7. Drafta D, Schindler AE, Stroe E, et al. Age-related changes of plasma steroids in normal adult males. J Steroid Biochem 1982 Dec;17(6):683-7.
8. Suzuki K, Inaba S, Takeuchi H, et al. Endocrine environment of benign prostatic hyperplasia—relationships of sex steroid hormone levels with age and the size of the prostate. Nippon Hinyokika Gakkai Zasshi 1992 May;83(5):664-71 (in Japanese).
9. Leowattana W. DHEAS as a new diagnostic tool. Clin Chim Acta. 2004 Mar;341(1-2):1-15.
10. Zenk JL, Kuskowski MA. The use of 3-acetyl-7-oxo-dehydroepiandrosterone for augmenting immune response in the elderly. Presented at meeting of FASEB, April 17, 2004.
11. Bobyleva V, Bellei M, Kneer N, et al. The effects of the ergosteroid 7-oxodehydroepiandrosterone on mitochondrial membrane potential: possible relationship to thermogenesis. Arch Biochem Biophys. 1997 May 1;341(1):122-8.
12. Lardy H, Partridge B, Kneer N, et al. Ergosteroids: induction of thermogenic enzymes in liver of rats treated with steroids derived from dehydroepiandrosterone. Proc Natl Acad Sci USA. 1995 Jul 3;92(14):6617-9.
13. Schottner M, Gansser D, Spiteller G. Lignans from the roots of Urtica dioica and their metabolites bind to human sex hormone binding globulin (SHBG). Planta Med 1997 Dec;63(6):529-32.
14. Kangas L, Saarinen N, Mutanen M, et al. Antioxidant and antitumor effects of hydroxymatairesinol (HM-3000, HMR), a lignan isolated from the knots of spruce. Eur J Cancer Prev. 2002;11(Suppl 2):S48-57.
15. Heald CL, Ritchie MR, Bolton-Smith C, et al. Phyto-oestrogens and risk of prostate cancer in Scottish men. Br J Nutr. 2007 Aug;98(2):388-96.
16. Hedelin M, Klint A, Chang ET, et al. Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden). Cancer Causes Control. 2006 Mar;17(2):169-80.
17. Dalais FS, Ebeling PR, Kotsopoulos D, et al. The effects of soy protein containing isoflavones on lipids and indices of bone resorption in postmenopausal women. Clin Endocrinol (Oxf). 2003 Jun;58(6):704–9.
18. Kardinaal AFM, Morton MS, Bruggemann-Rotgans IEM, et al. Phyto-estrogen excretion and rate of bone loss in postmenopausal women. Eur J Clin Nutr. 1998 Nov;52(11):850–5.
19. Ho SC, Chan SG, Yi Q, et al. Soy intake and the maintenance of peak bone mass in Hong Kong Chinese women. J Bone Miner Res. 2001 Jul;16(7):1363-9.
20. Mei J, Yeung SS, Kung AW. High dietary phytoestrogen intake is associated with higher bone mineral density in post-menopausal but not premenopausal women. J Clin Endocrinol Metab. 2001 Nov;86(11):5217–21.
21. Morabito N, Crisafulli A, Vergara C, et al. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res. 2002 Oct;17(10):1904–12.
22. Kim MK, Chung BC, Yu VY, et al. Relationships of urinary phytoestrogen excretion to BMD in postmenopausal women. Clin Endocrinol (Oxf). 2002 Mar;56(3):321–8.
23. Chiechi LM, Secreto G, D’Amore M, et al. Efficacy of a soy rich diet in preventing postmenopausal osteoorosis: the men’s randomized trial. Maturitas. 2002 Aug 30;42(4):295–300.
24. Alekel DL, Germain AS, Peterson CT, et al. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr. 2000 Sep;72(3):844–52.
25. Potter S, Baum J, Teng H, et al. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr. 1998 Dec;68(6 Suppl):1375S-9.
26. Crouse III JR, Morgan T, Terry JG, et al. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med. 1999 Sep 27;159(7):2070–6.
27. Merz-Demlow BE, Duncan AM, Wangen KE, et al. Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. Am J Clin Nutr. 2000 Jun;71(6):1462–9.
28. Wangen KE, Duncan AM, Xu X, et al. Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hyper-cholesterolemic postmenopausal women. Am J Clin Nutr. 2001 Feb;73(2):225–31.
29. Teede HJ, Dalais FS, Kotsopoulos D, et al. Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo controlled study in men and post-menopausal women. J Clin Endocrinol Metab. 2001 Jul;86(7):3053–60.
30. Jayagopal V, Albertazzi P, Kilpatrick ES, et al. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care. 2002 Oct;25(10):1709–1714.
31. Lemay A, Dodin S, Kadri N, et al. Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterolemic menopausal women. Obstet Gynecol. 2002 Sep;100(3):495–504.
32. Sanders TAB, Dean TS, Grainger D, et al. Moderate intakes of intact soy protein rich in isoflavones compared with ethanolextracted soy protein increase HDL but do not influence transforming growth factor beta(1) concentrations and hemostatic risk factors for coronary heart disease in healthy subjects. Am J Clin Nutr. 2002 Aug;76(2):373–7.
33. De Kleijn MJJ, Van der Schouw YT, Wilson PWF, et al. Dietary intake of phytoestrogens is associated with a favorable metabolic cardiovascular risk profile in postmenopausal US women: the Framingham Study. J Nutr. 2002 Feb;132(2):276–82.
34. Dai Q, Franke AA, Jin F, et al. Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol Biomarkers Prev. 2002 Sep;11(9):815–21.
35. Duffy R, Wiseman H, File SE. Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones. Pharmacol Biochem Behav. 2003 Jun;75(3):721–9.
36. www.nhlbi.nih.gov/new/ press/02-07-09.html. Accessed September 17, 2008. NHLBI Stops Trial of Estrogen Plus Progestin Due to Increased Breast Cancer Risk, Lack of Overall Benefit. NATIONAL INSTITUTES OF HEALTH, National Heart, Lung, and Blood Institute EMBARGOED FOR RELEASE Tuesday, July 9, 2002.
37. Brunelli E, Minassi A, Appendino G, et al. 8-Prenylnaringenin, inhibits estrogen receptor-alpha mediated cell growth and induces apoptosis in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol. 2007 Nov-Dec;107(3-5):140-8.
38. Heyerick A, Vervarcke S, Depypere H, et al. A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas. 2006 May 20;54(2):164-75.
39. Erkkola et al. 2008 – In preparation to publication. 40. Udani J, Hardy M. The effect of HMRlignan on mammalian lignan and estrogen metabolite levels in post-menopausal women: A randomized, double-blind, single dummy, parallel group, pilot study. Nov 6, 2007. |